Psychoeducation in schizophrenia: 7-Year follow-up concerning rehospitalization and days in hospital in the Munich psychosis information project study

Journal of Clinical Psychiatry

Volumn 68, Issue 6, 2007, Pages 854-861

  Bäuml, Josef ^a   Pitschel Walz, Gabriele ^a   Volz, Anja ^a   Engel, Rolf R ^b   Kissling, Werner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HOSPITAL; MULTICENTER STUDY; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOEDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL INTERACTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34347335495     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0605     Document Type: Article

References (36)

1. American Psychiatric Association. Guidelines for Treatment of Schizophrenia. Washington, DC: American Psychiatric Association; 2004
2. DGPPN. Behandlungsleitlinie Schizophrenie. Darmstadt, Germany: Steinkopff Verlag; 2006
3. Rummel C, Pitschel-Walz G, Bäuml J, et al. Umfrage zur aktuellen Versorgungssituation im Bereich Psychoedukation in deutschsprachigen Ländern. Nervenarzt 2004;75(suppl 2):S48
4. Bäuml J, Pitschel-Walz G. Psychoedukation bei schizophrenen Erkrankungen. Konsensuspapier der Arbeitsgruppe, Psychoedukation bei schizophrenen Erkrankungen. Stuttgart, Germany: Schattauer Verlag; 2003
5. Bäuml J, Pitschel-Walz G, Berger H, et al. Arbeitsbuch PsychoEdukation bei Schizophrenien. Stuttgart, Germany: Schattauer Verlag; 2005
6. Merinder L. Patient education in schizophrenia: a review. Acta Psychiatr Scand 2000;102:98-106
7. Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev 2000:CD002831
8. Schooler N, Keith S, Severe J, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia. Arch Gen Psychiatry 1997;54:453-463
9. Hahlweg K, Dose M. Schizophrenie. Göttingen, Germany: Hogrefe; 1998
10. Leucht S, Barnes TRE, Kissling W, et al. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 2003;160:1209-1222
11. Pitschel-Walz G, Bäuml J, Bender W, et al. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study. J Clin Psychiatry 2006;67: 443-452
12. Fenton W, Bleyler C, Heinssen R. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23:637-651
13. Knapp M, King D, Pugner K, et al. Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry 2004;184;509-516
14. Lacro J, Dunn L, Dolder C, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909
15. Wiedemann G, Klingberg S, Pitschel-Walz G, et al. Psychoedukative Interventionen in der Behandlung von Patienten mit schizophrenen Störungen. Der Nervenarzt 2003;74:789-808
16. McEvoy J. The relationship between insight into psychosis and compliance with medications. In: Amador X, David A, eds. Insight and Psychosis. Oxford, UK: University Press; 2004:311-333
17. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223
18. Pitschel-Walz G, Leucht S, Bäuml J, et al. The effect of family interventions on relapse and rehospitalization in schizophrenia - a meta-analysis. Schizophr Bull 2001;27:73-92
19. Tarrier N, Barrowclough C, Porceddu K, et al. The Salford Family Intervention Project: relapse rates of schizophrenia at five and eight years. Br J Psychiatry 1994;165:829-832
20. Hornung WP, Feldmann R, Klingberg S, et al. Long-term effects of a psychoeducational psychotherapeutic intervention for schizophrenic outpatients and their key-persons - results of a five-year follow-up. Eur Arch Psychiatry Clin Neurosci 1999;249:162-167
21. Bäuml J. Psychosen aus dem schizophrenen Formenkreis. Ein Ratgeber für Patienten und Angehörige. Heidelberg, Germany: Springer Verlag: 1994
22. Jahn T, Mussgay L. Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophrenie-Studien: ein Vorschlag zur Berechnung von Chlorpromazin-Äquivalenten. Zeitschrift für klinische Psychologie 1989; Band XVIII, Heft 3:257-267
23. Woods SW. Chlorpromazine-equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667
24. Overall JE, Gorman DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
25. Global Assessment of Functioning. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987:12
26. Priebe S. Lancashire Quality of Life Profile-German version. Berliner Lebensqualitätsprofil (BeLP). In: Salek M, ed. Compendium of Quality of Life Instruments. Chichester, England: Wiley & Sons; 1998;3:14d-14e
27. Rosenthal R. Meta-Analytic Procedures for Social Research. Rev ed. Newbury Park, Calif: Sage; 1991. Applied Social Research Methods Series; vol 6
28. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-486
29. Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse - a meta-analysis. Arch Gen Psychiatry 1998;55:547-552
30. Leucht S, Pitschel-Walz G, Abraham D, et al. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trials. Schizophr Res 1999;35:51-68
31. Valmaggia L, van der Gaag M, Tarrier N, et al. Cognitive-behavioral therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Br J Psychiatry 2005;186:324-330
32. Rummel-Kluge C, Pitschel-Walz G, Bäuml J, et al. Psychoeducation in schizophrenia - results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull 2006;32:765-775
33. Turkington D, Kingdon D, Weiden J. Cognitive behavior therapy for schizophrenia. Am J Psychiatry 2006;163:365-373
34. Heinz A, Romero B, Gallinat J, et al. Molecular brain imaging and the neurobiology and genetics of schizophrenia. Pharmacopsychiatry 2003;36(suppl 3):S152-S157
35. Ascher-Svanum H, Faries DE, Zhu B, et al. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 2006;67:453-460
36. Bäuml J, Froböse T, Kraemer S, et al. Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families. Schizophr Bull 2006;32(suppl 1):S1-S9